Business

Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021

SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its

articleTandem Diabetes Care, Inc.January 19, 20215/company/tandem-diabetes-care-inc/news/tandem-diabetes-care-to-announce-fourth-quarter-and-full-year-2020-financial-results
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021

About this update from Tandem Diabetes Care, Inc.

[{"type":"text","content":" SAN DIEGO--(BUSINESS WIRE)--\nTandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2020 results after the financial markets close on Wednesday, February 24, 2021. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its fourth quarter and full year 2020 financial and operating results.\n\nConference Call/Webcast Details:\nDate: February 24, 2021\nTime: 4:30 pm Eastern Time (1:30 pm Pacific Time)\nToll Free Dial-In Number: (855) 427-4396\nInternational Dial-In Number: (484) 756-4261\nConference ID: 7178576\nWebcast Link: https://edge.media-server.com/mmc/p/272ym8kz\n\nAn archive of the webcast will be available for 30 days following the event on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.\n\nAbout Tandem Diabetes Care, Inc.\n\nTandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandem’s flagship product, the t:slim X2™ insulin pump, is capable of remote software updates using a personal computer and features integrated continuous glucose monitoring, and optional automated insulin delivery technology. Tandem is based in San Diego, California.\n\nFollow Tandem Diabetes Care on Twitter @tandemdiabetes, use #tslimX2 and $TNDM.\nFollow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.\nFollow Tandem Diabetes Care on LinkedIn at www.linkedin.com/company/TandemDiabetes.\n\nTandem Diabetes Care is a registered trademark and t:slim X2 is a trademark of Tandem Diabetes Care, Inc.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210119005833/en/\n\nMedia Contact:\nSteve Sabicer\n714-907-6264\[email protected]\n\nInvestor Contact:\nSusan Morrison\n858-366-6900 x7005\[email protected]\n\nSource: Tandem Diabetes Care, Inc.","length":5440,"tagName":"div"}]

More updates from Tandem Diabetes Care, Inc.